Geng Tian Selected Research

Geng Tian Research Topics

Disease

52	Neoplasms (Cancer) 06/2022 - 06/2002
8	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 06/2002
6	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2009
5	COVID-19 01/2022 - 11/2020
5	Carcinogenesis 01/2020 - 06/2002
4	Lung Neoplasms (Lung Cancer) 09/2020 - 07/2018
3	Infections 01/2022 - 04/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2018
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
3	Hypoxia (Hypoxemia) 01/2018 - 01/2003
3	Stomach Neoplasms (Stomach Cancer) 03/2017 - 06/2002
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2020
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 05/2021
2	Insulin Resistance 04/2021 - 10/2012
2	Type 2 Diabetes Mellitus (MODY) 04/2021 - 09/2014
2	Cognitive Dysfunction 01/2021 - 09/2014
2	Lymphatic Metastasis 01/2021 - 04/2014
2	Hyperglycemia 10/2020 - 01/2016
2	Anemia 12/2018 - 01/2017
2	Liver Neoplasms (Liver Cancer) 04/2018 - 06/2015
2	Pathologic Neovascularization 10/2017 - 11/2016
2	Inflammation (Inflammations) 10/2017 - 05/2014
2	Adenocarcinoma 08/2016 - 06/2002
2	Ischemia 08/2015 - 01/2003
2	Amyloidosis 03/2015 - 08/2011
2	Hearing Loss (Hearing Impairment) 06/2014 - 12/2013
1	Proteinuria 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Thyroid Nodule (Nodule, Thyroid) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Endometriosis 09/2021

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
9	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 08/2004
5	Pharmaceutical PreparationsIBA 06/2022 - 09/2020
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 12/2018
4	Messenger RNA (mRNA)IBA 01/2020 - 07/2004
4	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 10/2012
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 01/2003
3	AntigensIBA 12/2019 - 08/2004
2	ferric oxide (iron oxide)IBA 06/2022 - 02/2022
2	Biological ProductsIBA 06/2022 - 06/2009
2	Cysteine (L-Cysteine)FDA Link 06/2022 - 04/2014
2	Circular RNAIBA 01/2022 - 05/2021
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2016
2	LDL CholesterolIBA 01/2022 - 11/2015
2	Vascular Endothelial Growth Factor BIBA 04/2021 - 01/2016
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2014
2	EnzymesIBA 01/2021 - 08/2015
2	Estrogen ReceptorsIBA 01/2021 - 01/2019
2	AntioxidantsIBA 10/2020 - 08/2015
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2017
2	Glutathione (Reduced Glutathione)IBA 12/2019 - 05/2002
2	Superoxide DismutaseIBA 12/2019 - 01/2019
2	MicroRNAs (MicroRNA)IBA 10/2019 - 01/2014
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2018 - 03/2017
2	Receptor for Advanced Glycation End ProductsIBA 07/2017 - 04/2016
2	Interleukin-10 (Interleukin 10)IBA 07/2017 - 08/2016
2	HDL CholesterolIBA 11/2015 - 03/2015
2	Sirtuin 1IBA 08/2015 - 06/2014
2	Apolipoprotein A-II (Apolipoprotein A2)IBA 03/2015 - 08/2011
2	Transcription Factors (Transcription Factor)IBA 01/2014 - 07/2010
2	Fluorouracil (Carac)FDA LinkGeneric 06/2009 - 06/2009
2	DNA VaccinesIBA 08/2004 - 01/2004
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2002 - 06/2002
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2002 - 06/2002
2	nimesulide (Aulin)IBA 06/2002 - 06/2002
1	VanadiumIBA 06/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022
1	Liposomes (Liposome)IBA 06/2022
1	Ligases (Synthetase)IBA 06/2022
1	Protein CoronaIBA 02/2022
1	Transferrin (beta 2 Transferrin)IBA 02/2022
1	PyrimidinesIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Aldo-Keto Reductase Family 1 Member C3IBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Nucleic AcidsIBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	AcidsIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Kallikreins (Kallikrein)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Angiogenesis InhibitorsIBA 09/2021
1	N-benzyl-N,1-dimethyl-2-propynylamineIBA 07/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2021
1	Blood Glucose (Blood Sugar)IBA 04/2021

Therapy/Procedure

17	Therapeutics 06/2022 - 06/2009
5	Drug Therapy (Chemotherapy) 06/2022 - 06/2002
4	Immunotherapy 01/2022 - 12/2019
3	Precision Medicine 06/2022 - 08/2020
2	Catheters 04/2011 - 07/2004
1	Photothermal Therapy 06/2022
1	Radiotherapy 01/2022
1	Transplantation 01/2022